News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current XRTX market cap is 5.52M. The company's latest EPS is CAD -0.7432 and P/E is -3.43.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.69M | -1.4M | -1.16M | -1.28M | -969k |
| Net Income | -1.83M | -1.69M | -1.33M | 2.7M | -3.02M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -368k | -1.14M | -2.42M | -12.33M | -5.53M |
| Net Income | -629k | -1.28M | -1.65M | -9.49M | -2.16M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 9.66M | 7.8M | 6.64M | 5.47M | 6.05M |
| Total Liabilities | 599k | 403k | 554k | 826k | 3.56M |
| Total Equity | 9.06M | 7.4M | 6.09M | 4.64M | 2.49M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 1.09M | 2.29M | 22.04M | 16.75M | 5.47M |
| Total Liabilities | 1.3M | 1.03M | 5.3M | 7.29M | 826k |
| Total Equity | -211k | 1.26M | 16.74M | 9.47M | 4.64M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -2.48M | -4.21M | -5.29M | -6.58M | -1.31M |
| Investing | -20k | -29k | -36k | -46k | -3k |
| Financing | -23k | -32k | -49k | -361k | 1.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -249k | -728k | -6.06M | -11.97M | -6.58M |
| Investing | -7k | -14k | -40k | -60k | -46k |
| Financing | 55k | 855k | 24.46M | 6.43M | -361k |
| Market Cap | 5.52M |
| Price to Earnings Ratio | -3.43 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.15 |
| Price to Book Ratio | 1.6 |
| Dividend Yield | - |
| Shares Outstanding | 2.9M |
| Average Volume (1 week) | 29.48k |
| Average Volume (1 Month) | 190.1k |
| 52 Week Change | -68.86% |
| 52 Week High | 7.524 |
| 52 Week Low | 1.52 |
| Spread (Intraday) | 0.15 (8.29%) |
| Company Name | XORTX Therapeutics Inc |
| Address |
550 burrard street, suite 2900 vancouver, british columbia V6C OA3 |
| Website | https://www.xortx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
